Gerresheimer, a provider of drug delivery systems and other products to the pharma industry, has reported revenues of EUR 285.1m for the third quarter of the 2011 financial year, a rise of 9.9% from the same period last year.
Subscribe to our email newsletter
The company has posted a net income of EUR19.2m for the quarter, indicating a rise by 36% ascompared to the corresponding period of the previous year.
Adjusted earnings per share rose by 35% to EUR 0.70
Gerresheimer has posted adjusted EBITDA of EUR 57.1m in the third quarter of 2011, as compared to EUR53.3m in the prior year.